Effect of on Liver Diseases: A Systematic Review.

We aimed to systematize the results of published studies on the use of (SB) for the treatment of various liver disorders (CRD42022378050). Searches were conducted using PubMed and Scopus on 1 August 2022. The PubMed search was updated on 15 June 2024.

Efficacy and Safety of a Probiotic Containing CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study.

(1) : The aim was to evaluate the effectiveness of the probiotic containing in the treatment of small intestinal bacterial overgrowth (SIBO) in patients with decompensated cirrhosis. (2) : This was a blinded, randomized, placebo-controlled study. (3) : After 3 months of treatment, SIBO was absent in 80.